Replies to Post #180600 onBiotech Values

Replies to post #180600 on Biotech Values

Replies to #180600 on Biotech Values

07/22/14 3:39 PM

#180603 RE: masterlongevity #180600

PTLA—I don't have anything to add to the comments in #msg-104066689 (and the links embedded there).

08/06/14 5:18 PM

#181002 RE: masterlongevity #180600

PTLA—Do you…have any thoughts on Cerdulatinib? The barrier for entry is pretty high in NHL/CLL.

According to today’s CC, based on in vitro data, PTLA is targeting DLBCL and Ibruvica-refractory CLL.

Go Ad-Free